For instance, a study involving 277 Danish persons without diabetes found that the gut microbiota of insulin-resistant patients had an increased capacity to manufacture branched-chain amino acids (BCAAs) and elevated serum BCAA levels [42]. This evidence concerns the gene INS and diabetes mellitus.